NIH clinical trial shows remdesivir accelerated recovery from advanced COVID-19
On Apr. 29, 2020, the National Institutes of Health (NIH) announced that hospitalized patients with advanced COVID-19 and…
NIH mobilized national innovation RADx initiative for COVID-19 diagnostics
On Apr. 29, 2020, the NIH announced a new initiative aimed at speeding innovation, development and commercialization of…
RedHill Biopharma announced agreement with NIAID to evaluate RHB-107 against COVID-19
On Apr. 20, 2020, RedHill Biopharma announced an agreement with the National Institute of Allergy and Infectious Diseases…
CDC | COVID-19 | Life Science History | NIH
The NIH launched a public-private partnership to speed COVID-19 vaccine and treatment options
On Apr. 17, 2020, the NIH and the Foundation for the NIH are bringing together more than a…
Antiviral remdesivir prevented disease progression in monkeys with COVID-19
On Apr. 17, 2020, the NIH announced that early treatment with the experimental antiviral drug remdesivir significantly reduced…
OHSU received more than $11 million to continue brain, cognitive development research
On Apr. 17, 2020, the NIH announced nearly $290 million of new funding for seven years to research…
IVI, INOVIO, and KNIH partner with CEPI in phase 1/2 clinical trial of INOVIO’s COVID-19 DNA vaccine in South Korea
On Apr. 16, 2020, Ihe International Vaccine Institute (IVI) announced that the Coalition for Epidemic Preparedness Innovations (CEPI)…
Landmark study of adolescent brain development renewed for additional seven years
On Apr. 15, 2020, the National Institutes of Health renewed its commitment to the Adolescent Brain Cognitive Development…
NIH BRAIN Initiative tool helps researchers watch neural activity in 3D
On Apr. 13, 2020, an ultra-fast, 3D imaging technique called SCAPE microscopy, developed through the National Institutes of…
NIH began study to quantify undetected cases of coronavirus infection
On Apr. 10, 2020, a new study has begun recruiting at the NIH in Bethesda, Maryland, to determine…
Autoimmunity may be rising in the United States
On Apr. 8, 2020, NIH scientists and collaborators report that autoimmunity, a condition in which the bodyï¾’s immune…
Biotechnology | Diagnostics | Disease | Genomics | Life Science News | Neurology | NIH | Therapeutics
Single mutation leads to big effects in autism-related gene
On Apr. 3, 2020, a new study in Neuron offers clues to why autism spectrum disorder (ASD) is…
NIH researchers discovered gene for rare disease of excess bone tissue growth
On Mar. 31, 2020, NIH researchers announced they had discovered a second gene that causes melorheostosis, a rare…
Emory University new site in NIH-sponsored coronavirus vaccine study
On Mar. 27, 2020, Emory’s Vaccine and Treatment Evaluation Unit (VTEU) announced participation in a clinical trial testing…
Biotechnology | COVID-19 | Diagnostics | Life Science News | Medical Device | Medicine | NIH | Non-Profit Research | Therapeutics
National Library of Medicine expanded access to coronavirus literature through PubMed Central
On Mar. 25, 2020, the National Library of Medicine (NLM), part of the National Institutes of Health, announced…
The Simmons Cancer Center joined elite National Comprehensive Cancer Network
On Mar. 24, 2020, the Harold C. Simmons Comprehensive Cancer Center at UT Southwestern announced it had joined…
COVID-19 | Diagnostics | Life Science News | NIH | Non-Profit Research | Therapeutics | U.S. Congress | Vaccine
NIH online resources support COVID-19 workers training to protect their own health
On Mar. 23, 2020, the National Institutes of Health (NIH) announced that it had launched an important online…
NIH shifted non-mission-critical laboratory operations to minimal maintenance phase
On Mar. 20, 2020, to further reduce the risk of transmission of COVID-19 and enhance the safety of…
NIH researchers discovered tooth-enamel protein in eyes with dry AMD
On Mar. 17, 2020, researchers at the National Eye Institute (NEI) reported finding a protein that normally deposits…
Research revealed new coronavirus stable for hours on surfaces
On Mar. 17, 2020, the virus that causes coronavirus disease 2019 (COVID-19) was stable for several hours to…
Moderna announced first participant dosed in NIH-led phase 1 study of mRNA vaccine against novel Coronavirus
On Mar. 16, 2020, Moderna announced it has released the first batch of mRNA-1273, the Companyï¾’s vaccine against…
NIH Reported First Known Employee with COVID-19 Infection
On Mar. 15, 2020, the National Institutes of Health (NIH) informed its staff that it had its first…
Biotechnology | COVID-19 | Diagnostics | Life Science News | NIH | Non-Profit Research | Therapeutics
Emory University among U.S. sites to host clinical trial for COVID-19 treatment
On Mar. 12, 2020, Emory University announced it was participating in a National Institutes of Health (NIH) sponsored…
Vir Biotec announced research collaboration with NIH Vaccine Research Center on antibodies against coronaviruses
On Mar. 11, 2020, Vir Biotech announced a research collaboration agreement with the NIH to advance characterization and…
Biotechnology | HIV | Life Science News | NIH
Drug-delivery technology leads to sustained HIV antibody production in NIH study
On Mar. 9, 2020, researchers from the National Institute of Allergy and Infectious Diseases (NIAID), part of the…
Scientists monitored brains replaying memories in real time
On Mar. 5, 2020, in a study of epilepsy patients, researchers at the National Institutes of Health (NIH)…
Testing with combined biopsy method improves prostate cancer diagnosis in NCI study
On Mar. 4, 2020, a method of testing for prostate cancer developed at the National Cancer Institute (NCI)…
CDC | COVID-19 | Diagnostics | Life Science News | NIH | Therapeutics | Vaccine
COVID-19 a reminder of the challenge of emerging infectious diseases
On Feb. 28, 2020, commentary appeared in The New England Journal of Medicine that discussed the emergence and…
NIH announced $1 million prize competition to target global disease diagnostics
On Feb. 25, 2020, the U. S. National Institutes of Health (NIH) announced it had launched a $1…
NIH clinical trial of remdesivir to treat COVID-19 began for adults with coronavirus disease
On Feb. 25, 2020, the National Institutes of Health (NIH) announced that a randomized, controlled clinical trial to…